ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 373

a Retrospective Study of Clinical Factors Influencing the Development of Overlapping Disease Features in Pediatric Patients with Chronic Recurrent Multifocal Osteomyelitis (CRMO) and Spondyloarthropathies (SpA)

Lillian Lim1, Jyoti Panwar2, Jennifer Stimec3, Shirley M.L. Tse4, Brian M. Feldman5 and Ronald M. Laxer6, 1Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada, 2Christian Medical College, Vellore, India, Vellore, India, 3The Hospital for Sick Children, Toronto, ON, Canada, 4Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 5Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 6Div of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: CRMO, osteomyelitis and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Pediatric Rheumatology – Clinical and Therapeutic Aspects Poster I: Autoinflammatory Disorders and Miscellaneous

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Some studies have suggested that chronic recurrent multifocal osteomyelitis (CRMO) and spondyloarthropathies (SpA) fall on a spectrum of disease, as they have been noted to share overlapping radiographic and clinical features. Most studies examining the link between inflammatory bone lesions and SpA have involved adult patients with SAPHO syndrome, with limited pediatric data. This study was done to test whether gender, HLA-B27 positivity, or age at onset of disease, influence whether and when pediatric CRMO and SpA patients develop overlapping features. Understanding of the clinical factors influencing overlap may have implications for earlier diagnosis, risk stratification, and treatment options.

Methods:

This was a retrospective inception cohort study of SickKids hospital charts. Eligible pediatric patients diagnosed with either CRMO or SpA between January 2000 and December 2016 were collected using the SickKids Rheumatology patient database. Using a secure web application (REDCap), we collected and compared the clinical, laboratory, and radiographic data of 40 randomly sampled patients from each of the CRMO and SpA groups. The MRIs were re-read by a radiologist. A patient was considered to have an overlap diagnosis if they had radiologic and clinical features of both CRMO and SpA.

Results:

7 patients (17.5%) and 8 patients (20.0%) from the CRMO and SpA groups, respectively, developed overlap. The median time to overlap was 36.0 months and 31.5 months, respectively. A survival (time-to-event) analysis, using the Kaplan-Meier approach, was used to show the proportion of patients without overlap features, since time of symptom onset. 28% of the entire sample population was HLA-B27 positive. Multivariable regression models using the Cox Proportional Hazards regression technique showed that the overall likelihood ratio test was not statistically significant (p=0.59), with hazard ratios of 1.11, 0.91, and 1.17 for each of male gender, HLA-27 positivity, and age at symptom onset, respectively.

Conclusion:

Patient gender, HLA-B27 positivity, and age of symptom onset did not appear to increase the risk of developing overlap features of CRMO and SpA in our sample population. Nonetheless, overlap of clinical and radiologic features was found in approximately 20% of our patients. CRMO and SpA may represent two diseases on the same spectrum, though prospective studies with longer follow up are needed. Our study was limited by the small sample size and retrospective design, as it is unknown whether overlap may occur in the time exceeding clinical follow-up. Study of their clinical overlap is important to allow a better understanding of how to recognize and treat these rare diseases.


Disclosure: L. Lim, None; J. Panwar, None; J. Stimec, None; S. M. L. Tse, None; B. M. Feldman, None; R. M. Laxer, None.

To cite this abstract in AMA style:

Lim L, Panwar J, Stimec J, Tse SML, Feldman BM, Laxer RM. a Retrospective Study of Clinical Factors Influencing the Development of Overlapping Disease Features in Pediatric Patients with Chronic Recurrent Multifocal Osteomyelitis (CRMO) and Spondyloarthropathies (SpA) [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/a-retrospective-study-of-clinical-factors-influencing-the-development-of-overlapping-disease-features-in-pediatric-patients-with-chronic-recurrent-multifocal-osteomyelitis-crmo-and-spondyloarthropat/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-retrospective-study-of-clinical-factors-influencing-the-development-of-overlapping-disease-features-in-pediatric-patients-with-chronic-recurrent-multifocal-osteomyelitis-crmo-and-spondyloarthropat/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology